Aktis Oncology, Inc. (AKTS) stock
AKTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$16.10−0.21 (-1.29%)
Close on Nov 18, 2026Market cap $895.47MP/E –Yield –
Aktis Oncology market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Aktis Oncology's market cap was $910.72M on Nov 11, 2026.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $910.72M | – |
See a number that looks wrong?